Cells, 2025 · DOI: 10.3390/cells14020064 · Published: January 7, 2025
This study compares neural stem/progenitor cells (NSPCs) from adult human spinal cords with those derived from induced pluripotent stem cells (iPSCs). The goal is to understand how well iPSC-derived NSPCs mimic real spinal cord NSPCs, which is important for developing cell therapies for spinal cord injuries. Researchers looked at the transcriptomic profiles (gene activity) and functional properties of three types of NSPCs: those directly from the spinal cord, those made from iPSCs and directed to become spinal cord cells (iPSC-SC), and those made from iPSCs and directed to become forebrain cells (iPSC-Br). The study found that iPSC-Br NSPCs were more similar to real spinal cord NSPCs in terms of gene activity and their ability to turn into neurons. This suggests that iPSC-Br NSPCs could be a better option for cell therapies aimed at repairing spinal cord injuries.
iPSC-Br NSPCs show promise as a cell source for autologous therapies targeting spinal cord regeneration due to their transcriptomic similarity to bona fide spinal cord NSPCs.
Donor-specific variability highlights the need for individualized approaches in stem cell therapy development, considering genetic and epigenetic factors.
The distinct transcriptomic profiles of iPSC-SC and iPSC-Br NSPCs provide valuable insights into neural differentiation and regional specification, aiding in understanding neural development.